Amundi Decreases Stock Position in Integer Holdings Corporation $ITGR

Amundi lessened its position in Integer Holdings Corporation (NYSE:ITGR) by 19.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,000 shares of the medical equipment provider’s stock after selling 3,372 shares during the quarter. Amundi’s holdings in Integer were worth $1,625,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. TENOR CAPITAL MANAGEMENT Co. L.P. purchased a new position in shares of Integer in the first quarter valued at approximately $4,861,000. Cubist Systematic Strategies LLC acquired a new stake in shares of Integer in the first quarter valued at approximately $1,035,000. Paradigm Capital Management Inc. NY increased its holdings in shares of Integer by 426.2% in the first quarter. Paradigm Capital Management Inc. NY now owns 22,100 shares of the medical equipment provider’s stock valued at $2,608,000 after purchasing an additional 17,900 shares during the last quarter. DRW Securities LLC purchased a new position in Integer during the first quarter worth approximately $220,000. Finally, The Manufacturers Life Insurance Company lifted its position in Integer by 40.2% during the first quarter. The Manufacturers Life Insurance Company now owns 213,741 shares of the medical equipment provider’s stock worth $25,224,000 after buying an additional 61,273 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Wall Street Analysts Forecast Growth

ITGR has been the topic of a number of analyst reports. Truist Financial reduced their price objective on Integer from $145.00 to $137.00 and set a “buy” rating on the stock in a research report on Friday, July 25th. Citigroup upgraded Integer from a “hold” rating to a “strong-buy” rating and lifted their price objective for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Wells Fargo & Company reduced their price objective on Integer from $152.00 to $132.00 and set an “overweight” rating on the stock in a research report on Friday, July 25th. Wall Street Zen upgraded Integer from a “hold” rating to a “buy” rating in a research report on Saturday, August 30th. Finally, Raymond James Financial reduced their price objective on Integer from $150.00 to $143.00 and set an “outperform” rating on the stock in a research report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $140.25.

Integer Price Performance

ITGR stock opened at $101.53 on Friday. The company has a current ratio of 3.41, a quick ratio of 2.18 and a debt-to-equity ratio of 0.72. The company has a market capitalization of $3.56 billion, a PE ratio of 44.73, a P/E/G ratio of 0.82 and a beta of 1.03. Integer Holdings Corporation has a 12-month low of $100.89 and a 12-month high of $146.36. The business’s fifty day moving average price is $109.53 and its 200 day moving average price is $115.96.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.02). The firm had revenue of $476.00 million during the quarter, compared to analysts’ expectations of $464.37 million. Integer had a net margin of 4.61% and a return on equity of 12.27%. Integer’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.30 EPS. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. On average, sell-side analysts anticipate that Integer Holdings Corporation will post 6.01 EPS for the current year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.